Biotechnology(BK4139),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BK4139 Biotechnology

Not Yet Opened 10-28 16:00:00 EDT

89.43

+1.17

+1.33%

High89.75	Low87.00	Vol871.70M
Open88.26	D1 Closing88.26	Amplitude3.11%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O20.38B	T/O Rate--	Tradable Shares0.00
P/B1.104977	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK4139","market":"US","secType":"PLATE","nameCN":"Biotechnology","latestPrice":89.42746,"timestamp":1793217599999,"preClose":88.2564,"halted":0,"volume":871702671,"delay":0,"changeRate":0.013269,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":1.171059,"latestTime":"10-28 16:00:00 EDT","open":88.2564,"high":89.74683,"low":87.0042,"amount":20382616343.10546,"amplitude":0.031076,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1793280600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":1.104977,"peRate":-11.635218,"turnoverRate":0.024768,"increases":403,"decrements":105,"flats":10,"marketCap":2267108075883.125,"floatMarketCap":2084324015213.125},"requestUrl":"/m/hq/s/BK4139","defaultTab":"news","newsList":[{"id":"2679199421","title":"Lenz Therapeutics, Inc. : TD Cowen Cuts Target Price to $45 from $50","url":"https://stock-news.laohu8.com/highlight/detail?id=2679199421","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679199421?lang=en_us&edition=fundamental","pubTime":"2026-10-29 14:52","pubTimestamp":1793256756,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261029:nFWN46F0V8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4007","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679421392","title":"Chimeric Therapeutics Halts CHM-2101 CAR-T Trial After Safety Concerns","url":"https://stock-news.laohu8.com/highlight/detail?id=2679421392","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679421392?lang=en_us&edition=fundamental","pubTime":"2026-10-29 14:29","pubTimestamp":1793255349,"startTime":"0","endTime":"0","summary":"Chimeric Therapeutics Ltd. ( ($AU:CHM) ) has provided an update. Chimeric Therapeutics has halted enrolment and dosing in its Phase 1/2 clinical tr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/chimeric-therapeutics-halts-chm-2101-car-t-trial-after-safety-concerns?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/chimeric-therapeutics-halts-chm-2101-car-t-trial-after-safety-concerns?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4539","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679426407","title":"Switzerland's Idorsia 9M Revenue Flat, Quviviq Sales up 54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679426407","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679426407?lang=en_us&edition=fundamental","pubTime":"2026-10-29 14:16","pubTimestamp":1793254597,"startTime":"0","endTime":"0","summary":"Switzerland's Idorsia 9M revenue flat, QUVIVIQ sales up 54%OverviewSwiss biopharma firm's 9M 2026 revenue was flat yr/yr at CHF 172 mlnQUVIVIQ sales rose 54% yr/yr to CHF 142 mln in first nine monthsN","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261029:nL2N46F06M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BIIB","LU0320765992.SGD","BK4139","BK4533","BK4532","IE00B19Z9P08.USD","LU0109394709.USD","PBE","BMED","BK4585","IE00B19Z9Z06.USD","IE00B894F039.SGD","LU0234570918.USD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679426045","title":"Kiniksa Pharmaceuticals’ Missing Mine Safety Detail Raises Questions on Disclosure Practices","url":"https://stock-news.laohu8.com/highlight/detail?id=2679426045","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679426045?lang=en_us&edition=fundamental","pubTime":"2026-10-29 14:00","pubTimestamp":1793253634,"startTime":"0","endTime":"0","summary":"Kiniksa Pharmaceuticals Ltd. Class A (KNSA) has disclosed a new risk, in the Manufacturing category. Item 4 on mine safety disclosures is noted for...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kiniksa-pharmaceuticals-missing-mine-safety-detail-raises-questions-on-disclosure-practices?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kiniksa-pharmaceuticals-missing-mine-safety-detail-raises-questions-on-disclosure-practices?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KNSA","BK4505","BK4139","LU1559883803.SGD","LU0566484027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679754425","title":"Press Release: Molecular Partners Reports Q3 2026 Financial Results, Deepens Focus on Targeted Radiotherapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2679754425","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679754425?lang=en_us&edition=fundamental","pubTime":"2026-10-29 14:00","pubTimestamp":1793253600,"startTime":"0","endTime":"0","summary":"-- Dosing ongoing in fully recruited dose level 2 of MP0712 Phase 1/2a. study; initial safety data to be presented at North America Conference on. Lung Cancer in December 2026, efficacy data expected in 2027. -- Emerging clinical data from lead Radio-DARPin candidate MP0712 enables. -- Streamlining of organization, in line with corporate focus, to advance. -- Cash position of CHF 57.5 million  as of September 30,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4080","LU2463526074.USD","BK4539","BK4231","ASH","SITC","MOLN","BK4109"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679342575","title":"Press Release: ADDEX Increases Issued SHARE Capital to Create Treasury Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2679342575","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679342575?lang=en_us&edition=fundamental","pubTime":"2026-10-29 14:00","pubTimestamp":1793253600,"startTime":"0","endTime":"0","summary":"Chief Executive Officer       Partner, Halsin Partners","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ADXN","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679342365","title":"Genmab : Leerink Partners Raises Target Price to $65 from $60","url":"https://stock-news.laohu8.com/highlight/detail?id=2679342365","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679342365?lang=en_us&edition=fundamental","pubTime":"2026-10-29 13:05","pubTimestamp":1793250350,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261029:nFWN46F09Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","GMAB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679257844","title":"Earnings Surprise Setup Might Change The Case For Investing In Alkermes Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2679257844","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679257844?lang=en_us&edition=fundamental","pubTime":"2026-10-29 12:57","pubTimestamp":1793249845,"startTime":"0","endTime":"0","summary":"Alkermes recently entered its September 2026 earnings season with the market expecting a quarterly loss and higher revenue than the prior year, alongside a positive Earnings ESP of 50% and a Zacks Rank of 4.\nThe more interesting angle is how this setup tests Alkermes' ability to fund heavy orexin and LUMRYZ investment while still surprising on earnings after four straight EPS beats.\nWe will look at how Alkermes' investment narrative is shaped by expectations of another potential earnings...","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alks/alkermes/news/earnings-surprise-setup-might-change-the-case-for-investing","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alks/alkermes/news/earnings-surprise-setup-might-change-the-case-for-investing","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MEDX","JOYT","FBT","VGFPF","PSCH","IBRN","DECU","PMDE","VOTE","FEBU","RGLO","GXDW","PSIL","ALKS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178219687","title":"Shanxi Issues 15th Five-Year Plan for Intellectual Property Protection and Utilization","url":"https://stock-news.laohu8.com/highlight/detail?id=1178219687","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178219687?lang=en_us&edition=fundamental","pubTime":"2026-10-29 12:31","pubTimestamp":1793248265,"startTime":"0","endTime":"0","summary":"Recently, with the approval of the Shanxi Provincial Party Committee and the Shanxi Provincial Government, the Shanxi Provincial Intellectual Property Office, together with the Shanxi Provincial...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTNT","USRD","LRND","BK4139","WRND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679442869","title":"Benitec Biopharma Inc : Raymond James Raises Target Price to $17 from $14","url":"https://stock-news.laohu8.com/highlight/detail?id=2679442869","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679442869?lang=en_us&edition=fundamental","pubTime":"2026-10-29 12:24","pubTimestamp":1793247893,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261029:nFWN46F01S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BNTC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679428878","title":"Genmab : TD Cowen Raises Target Price to DKK 4526 from DKK 3435","url":"https://stock-news.laohu8.com/highlight/detail?id=2679428878","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679428878?lang=en_us&edition=fundamental","pubTime":"2026-10-29 12:12","pubTimestamp":1793247149,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261029:nFWN46F08R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GMAB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679802440","title":"Biogen : Truist Securities Raises Target Price to $260 from $235","url":"https://stock-news.laohu8.com/highlight/detail?id=2679802440","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679802440?lang=en_us&edition=fundamental","pubTime":"2026-10-29 11:35","pubTimestamp":1793244903,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261029:nFWN46E28H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PBE","IE00B894F039.SGD","LU0109394709.USD","BK4139","BK4533","LU0320765992.SGD","BIIB","BK4588","LU0234570918.USD","LU0889565916.HKD","BK4585","BK4532","IE00B19Z9P08.USD","BMED","IE00B19Z9Z06.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679444712","title":"Replimune Group, Inc. : Leerink Partners Raises Target Price to $31 from $19","url":"https://stock-news.laohu8.com/highlight/detail?id=2679444712","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679444712?lang=en_us&edition=fundamental","pubTime":"2026-10-29 11:14","pubTimestamp":1793243670,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261029:nFWN46E284:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["REPL","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679244451","title":"GridAI Grants Director Edward Borkowski 100,000 Restricted Stock Units","url":"https://stock-news.laohu8.com/highlight/detail?id=2679244451","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679244451?lang=en_us&edition=fundamental","pubTime":"2026-10-29 09:52","pubTimestamp":1793238754,"startTime":"0","endTime":"0","summary":"GridAI Grants Director Edward Borkowski 100,000 Restricted Stock UnitsGridAI Technologies awarded director Edward Borkowski 100,000 common shares on October 26, 2026.Borkowski acquired another 17,079 ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261029:nNDL9ZtcQ7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GRDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121491466","title":"BeOne Medicines Shares Open Nearly 4% Higher as Company Unveils Clinical Data for Multiple Solid Tumour Programs with Clear Future Development Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=1121491466","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121491466?lang=en_us&edition=fundamental","pubTime":"2026-10-29 09:32","pubTimestamp":1793237561,"startTime":"0","endTime":"0","summary":"BeOne Medicines (06160) opened nearly 4% higher. As of press time, the stock was up 3.73%, trading at HK$228.2, with a turnover of HK$36.279 million.On the news front, BeOne Medicines announced key...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1770034418.SGD","LU0828237510.HKD","LU0588546209.SGD","LU1719994722.HKD","KCAI","ONC","VXUS","BK1500","LU0307460666.USD","BK1588","BK4526","LU2328871848.SGD","BK0239","688235","LU0228659784.USD","LU1969619763.USD","06160","BK1583","LU1303224171.USD","LU1251922891.USD","BK1161","KURE","BK4139","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679444900","title":"How Investors May Respond To Cullinan Therapeutics (CGEM) Global Trial Clearance","url":"https://stock-news.laohu8.com/highlight/detail?id=2679444900","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679444900?lang=en_us&edition=fundamental","pubTime":"2026-10-29 09:18","pubTimestamp":1793236720,"startTime":"0","endTime":"0","summary":"Cullinan Therapeutics reported regulatory clearance in the U.S. and Australia to start a global Phase 1b/2a trial of velinotamig in relapsing and refractory ITP and wAIHA, alongside new Phase 2 zipalertinib data in NSCLC with active CNS metastases.\nThe move pushes Cullinan Therapeutics deeper into autoimmune cytopenias while also adding fresh clinical evidence around its EGFR and T cell engager pipeline. This raises practical questions on trial execution, cost allocation, and how management...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cgem/cullinan-therapeutics/news/how-investors-may-respond-to-cullinan-therapeutics-cgem-glob","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-cgem/cullinan-therapeutics/news/how-investors-may-respond-to-cullinan-therapeutics-cgem-glob","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","ISBC","BK4211","CGEM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679244185","title":"Mesoblast Says Q1 Net Revenues up 44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679244185","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679244185?lang=en_us&edition=fundamental","pubTime":"2026-10-29 09:17","pubTimestamp":1793236664,"startTime":"0","endTime":"0","summary":"BRIEF-Mesoblast Says Q1 Net Revenues Up 44%Oct 29 (Reuters)-Mesoblast LimitedMSB.AX:Q1 NET REVENUES UP 44%, NET OPERATIONAL CASH SPEND IMPROVED 86% VERSUS PRIOR YEARCASH AT SEPT 30, 2026 US$99 MILLION; Q1 OPERATING CASH SPEND US$2.1 MILLIONFurther company coverage:MSB.AX","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261029:nFWN46E2IM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","MESO","BK7501","BK4139","BK7067","MSB.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111916703","title":"UK car output jumps 36.3% in September","url":"https://stock-news.laohu8.com/highlight/detail?id=1111916703","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111916703?lang=en_us&edition=fundamental","pubTime":"2026-10-29 08:30","pubTimestamp":1793233822,"startTime":"0","endTime":"0","summary":"Industry data released on Thursday showed that UK car production rose sharply in September, partly because the same month last year was affected by a cyber incident that created a low base for...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SMMT","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679457694","title":"Press Release: Activity Report for Quarter Ended September 30, 2026 (Appendix 4C)","url":"https://stock-news.laohu8.com/highlight/detail?id=2679457694","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679457694?lang=en_us&edition=fundamental","pubTime":"2026-10-29 08:19","pubTimestamp":1793233140,"startTime":"0","endTime":"0","summary":"NEW YORK, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided its activity report for t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MESO","BK7501","BK7508","MSC","BK4006","BK4139","MSB","MSB.AU","BK4575","BK4022","BK4150","R","BK7067","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679445252","title":"PYC Therapeutics Held AU$655 Million Cash, Treasury Investments at September Quarter-End","url":"https://stock-news.laohu8.com/highlight/detail?id=2679445252","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679445252?lang=en_us&edition=fundamental","pubTime":"2026-10-29 08:14","pubTimestamp":1793232891,"startTime":"0","endTime":"0","summary":"PYC Therapeutics  said it had cash and treasury investments of AU$655 million at Sept. 30, according to a Thursday Australian bourse filing.The company said it has three investigational drug candidates with disease-modifying potential in clinical development, with a fourth expected to enter human trials in 2027.The company's third-quarter progress included its polycystic kidney disease program and its Phelan-McDermid syndrome program.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","LENZ","PYC.AU","BK4539","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":-0.001},{"period":"1month","weight":0.0088},{"period":"3month","weight":0.0413},{"period":"6month","weight":0.0717},{"period":"1year","weight":0.1241},{"period":"ytd","weight":0.1326}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"name":"BK4139","nameEN":"BK4139"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Biotechnology(BK4139),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Biotechnology(BK4139) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Biotechnology,BK4139,Biotechnology股票,Biotechnology股票老虎,Biotechnology股票老虎国际,Biotechnology行情,Biotechnology股票行情,Biotechnology股价,Biotechnology股市,Biotechnology股票价格,Biotechnology股票交易,Biotechnology股票购买,Biotechnology股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Biotechnology(BK4139),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Biotechnology(BK4139) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}